ARANESP 25 ug/mL
darbepoetin alfa · SOLUTION · Amgen, Inc
No Recall History
Plain English
ARANESP is a solution containing darbepoetin alfa at 25 ug/mL, taken intravenous. Manufactured by Amgen, Inc.
Key Facts
- Brand Name
- ARANESP
- Generic Name
- darbepoetin alfa
- NDC Code (Product)
55513-002- Manufacturer
- Amgen, Inc
- Strength
- 25 ug/mL
- Dosage Form
- SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- BLA103951
- Drug Class
- Erythropoiesis-stimulating Agent [EPC]
- Marketing Start
- 09/11/2006
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
death15,927 reports
hospitalisation6,117 reports
off label use2,527 reports
anaemia2,125 reports
haemoglobin decreased1,636 reports
product storage error1,623 reports
pneumonia1,464 reports
fatigue1,457 reports
dyspnoea1,403 reports
diarrhoea1,304 reports
Frequently Asked Questions
What is ARANESP used for?
ARANESP contains darbepoetin alfa. It is a solution taken intravenous. Consult your doctor for specific uses.
Is ARANESP a controlled substance?
ARANESP is not classified as a controlled substance by the DEA.
What is the generic name for ARANESP?
The generic name for ARANESP is darbepoetin alfa. There are no other listed brand versions of darbepoetin alfa.
What is the NDC code for ARANESP 25 ug/mL?
The NDC (National Drug Code) for ARANESP 25 ug/mL is 55513-002, listed by Amgen, Inc.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)